State Street Corp Geo Vax Labs, Inc. Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.62 - $1.11 $43,524 - $77,922	-70,200 Reduced 41.75%	97,942 $64,000
Q3 2022 Nov 15, 2022	BUY	$0.4 - $1.72 $58,400 - $251,120	146,000 Added 659.38%	168,142 $183,000
Q1 2022 May 16, 2022	BUY	N/A	442 Added 2.04%	22,142 $25,000
Q2 2021 Aug 16, 2021	BUY	N/A	21,700 New	21,700 $109,000

Ticker GOVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,744,000
Market Cap $69.3M
Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.